🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase III trial is studying vincristine, dactinomycin, and doxorubicin...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2006-11-06
Trial ID
NCT00352534
This phase III trial studies how well pembrolizumab works in treating patie...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2017-11-03
Trial ID
NCT03244384
This phase II trial studies the effect of rogaratinib in treating patients ...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-05-03
Trial ID
NCT04595747
The hypothesis of PAREPET is that hibernating myocardium (viable myocardium...
Status
Completed
Location
SUNYBuffalo
Start Date
2004-07
Trial ID
NCT01400334
Treatments Being Tested
This phase III trial studies how well radiation therapy with protons works ...
Status
Active Not Recruiting
Location
Emory Proton Therapy Center
Start Date
2018-01-26
Trial ID
NCT03186898
This phase II trial tests the combination of nivolumab and ipilimumab with ...
Status
Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2024-07-24
Trial ID
NCT05896839
This prospective pilot study will assess the feasibility of rh PSMA 7.3 pos...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2021-08-04
Trial ID
NCT04978675
Treatments Being Tested
This phase I/Ia trial finds the best dose and side effects of venetoclax gi...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2022-08-03
Trial ID
NCT04847453
This is a Phase III study to evaluate 68Ga Citrate PET/MRI for detection of...
Status
Withdrawn
Location
Stanford University
Start Date
2019-01-15
Trial ID
NCT04139395
This phase II trial tests how well retifanlimab with bevacizumab and hypofr...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-10-02
Trial ID
NCT06160206